InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,562.22
(
-0.04%
)
US TECH 100
19,270.80
(
-0.18%
)
Dow Jones
40,337.54
(
-0.19%
)
Brent Oil
80.81
(
-0.87%
)
Bitcoin
66,652.14
(
-1.41%
)
Post# of 252650
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: masterlongevity post# 94243

Sunday, 04/18/2010 5:16:19 AM

Sunday, April 18, 2010 5:16:19 AM

Post# of 252650
Bapineuzumab - IV every 13 weeks is indeed the less frequent IV dosing but Wyeth/Elan have a subcutaneous formulation (in phase II), which uses weekly injections and Bapineuzumab might end up with this formulation in order to reduce AE.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up